Organigram Global (OGI) Income towards Parent Company (2018 - 2026)
Organigram Global (OGI) posted quarterly Income towards Parent Company of $13.9 million for Q1 2026, down 53.06% year-over-year from $29.6 million in Q1 2025, and up 176.71% quarter-over-quarter from $5.0 million in Q4 2025.
Organigram Global (OGI) Income towards Parent Company (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Income towards Parent Company for 7 consecutive years, with $13.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company fell 53.06% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $48.5 million (up 96.19% YoY), while the FY2025 annual figure was $4.5 million, changed N/A from the prior year.
- Income towards Parent Company rose to $13.9 million in Q1 2026 per OGI's latest filing, from $5.0 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $29.6 million in Q1 2025 and bottomed at -$4.9 million in Q4 2024.
- Historically, Income towards Parent Company has averaged $10.9 million across 3 years, with a median of $9.5 million in 2025.
- Annual changes were most pronounced in 2025 — Income towards Parent Company soared 203.1% — and 2026, when it sank 53.06%.
- Organigram Global's Income towards Parent Company stood at -$4.9 million in 2024, then soared by 203.1% to $5.0 million in 2025, then jumped by 176.71% to $13.9 million in 2026.
- Business Quant data shows OGI's Income towards Parent Company at $13.9 million in Q1 2026, $5.0 million in Q4 2025, and $29.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Organigram Global | 152.57 Mn | 152.45 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.89 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Mar 31, 2025 | 29.59 Mn |
| Dec 31, 2024 | -4.87 Mn |
| May 31, 2021 | -104.73 Mn |
| Feb 28, 2021 | 100.73 Mn |
| Nov 30, 2020 | -34.34 Mn |
| Aug 31, 2020 | -166.07 Mn |
| May 31, 2020 | -64.27 Mn |
| Feb 29, 2020 | -6.83 Mn |
| Nov 25, 2019 | 15.25 Mn |
| May 31, 2019 | -7.60 Mn |
| Nov 30, 2018 | -38,000.00 |
| May 31, 2018 | -1.27 Mn |